ARCHIVES

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

OMB Backs Down, May Release New Construction Funds For UCLA, Salk, NYU

April 25, 1975

Milken Calls For Renewed War On Cancer, $20 Billion A Year International Effort

November 24, 1995

Coalition Agrees On Method To Coordinate Issues

March 21, 1980

White House Okays Committee ‘Kill’ Lists; Workshops To Plan Projects In Carcinogenesis

July 22, 1977

Compliance Grants Awarded, Contract Pending On Differences In Black/White Survival

November 19, 1982

In Brief: Adjuvant Chemotherapy Standard Practice For Breast Cancer At Milan, Bonadonna Says

May 7, 1976